Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
InChi: InChI=1S/C24H29ClN6OS/c1-30-10-12-31(13-11-30)9-3-8-26-24-27-15-19(25)22(29-24)21-14-18-17(4-2-5-20(18)33-21)23(32)28-16-6-7-16/h2
56S)-39-[[(2S)-6-amino-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]hexanoyl]amino]-12
PEAQX (10 and 20 mg/kg) shows enhanced locomotor activity in response to PCP challenge (4 mg/kg on PN28-35) compared to saline pretreatment (F3
It can be used to functionally replace Dkk protein in blocking Wnt signaling in many assay conditions (e
(dodecyloxy)sulfonic acid
TL02-59 Size:Contact [email protected] for quotation InChi: InChI=1S/C24H29ClN6OS/c1-30-10-12-31(13-11-30)9-3-8-26-24-27-15-19(25)22(29-24)21-14-18-17(4-2-5-20(18)33-21)23(32)28-16-6-7-16/h2TL02 59 is an orally active, selective Src family kinase Fgr inhibitor with an IC50 of 0. 03 nM. TL02 59 inhibits Lyn and Hck with IC50s of 0. 1 nM and 160 nM, respectively. TL02 59 potently suppresses acute myelogenous leukemia (AML) cell growth. Product information CAS Number: 1315330 17 6 Molecular Weight: 609. 64 Formula: C32H34F3N5O4 Chemical Name: 3 [(6,7 dimethoxyquinazolin 4 yl)oxy] N {4 [(4 ethylpiperazin 1 yl)methyl] 3